| Literature DB >> 25344702 |
Sven Lahme, Kathleen Trautwein, Annemieke Strijkstra, Marvin Dörries, Lars Wöhlbrand, Ralf Rabus.
Abstract
BACKGROUND: At high concentrations of organic substrates, microbial utilization of preferred substrates (i.e., supporting fast growth) often results in diauxic growth with hierarchical substrate depletion. Unlike the carbon catabolite repression-mediated discriminative utilization of carbohydrates, the substrate preferences of non-carbohydrate-utilizing bacteria for environmentally relevant compound classes (e.g., aliphatic or aromatic acids) are rarely investigated. The denitrifying alphaproteobacterium Magnetospirillum sp. strain pMbN1 anaerobically degrades a wide variety of aliphatic and aromatic compounds and is unique for anaerobic degradation of 4-methylbenzoate. The latter proceeds via a distinct reaction sequence analogous to the central anaerobic benzoyl-CoA pathway to intermediates of central metabolism. Considering the presence of these two different anaerobic "aromatic ring degrading" pathways, substrate preferences of Magnetospirillum sp. strain pMbN1 were investigated. Anaerobic growth and substrate consumption were monitored in binary and ternary mixtures of 4-methylbenzoate, benzoate and succinate, in conjuction with time-resolved abundance profiling of selected transcripts and/or proteins related to substrate uptake and catabolism.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25344702 PMCID: PMC4268860 DOI: 10.1186/s12866-014-0269-4
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Anaerobic growth of sp. strain pMbN1 with binary and ternary substrate mixtures of 4-methylbenzoate, benzoate and succinate. Growth behavior and substrate utilization profiles of Magnetospirillum sp. strain pMbN1 adapted to succinate (a,b) or 4-methylbenzoate (c,d).
Anaerobic growth of sp. strain pMbN1 with binary mixtures of aliphatic and aromatic acids
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||||
| Succinate (5 mM) |
| 0.30 | 0.19 | 2.1 ± 0.1 | 0.42 | 0.28 |
| Succinate (5 mM) | 4-Methylbenzoate (1 mM) | 0.61 | 0.24 | None | None | None |
|
| 4-Hydroxybenzoate (1 mM) | 0.43 | 0.27 | 3.3 ± 0.1 | 0.51 | 0.50 |
| Succinate (5 mM) | Phenylacetate (1 mM) | 0.66 | 0.25 | None | None | None |
| Succinate (5 mM) | Acetate (8 mM) | 0.53 | 0.23 | None | None | None |
|
| ||||||
| 4-Methylbenzoate (1.5 mM) |
| 0.27 | 0.29 | 4.0 ± 0.0 | 0.41 | 0.29 |
| 4-Methylbenzoate (1.5 mM) |
| 0.30 | 0.29 | 5.0 ± 0.0 | 0.45 | 0.28 |
|
| ||||||
| Acetate (8 mM) | Benzoate (1 mM) | 0.38 | 0.18 | None | None | None |
|
| 4-Methylbenzoate (1 mM) | 0.25 | 0.16 | 3.5 ± 0.0 | 0.32 | 0.24 |
| Pyruvate (6 mM) |
| 0.30 | 0.17 | 1.3 ± 0.3 | 0.54 | 0.37 |
| Pyruvate (6 mM) | 4-Methylbenzoate (1 mM) | 0.54 | 0.22 | None | None | None |
| Fumarate (5 mM) |
| 0.30 | 0.17 | 2.3 ± 0.0 | 0.43 | 0.29 |
| L-Malate (5 mM) |
| 0.31 | 0.44 | 2.6 ± 0.1 | 0.49 | 0.28 |
| Oxaloacetate (6 mM) |
| 0.31 | 0.19 | 1.0 ± 0.0 | 0.42 | 0.34 |
|
| ||||||
| 4-Hydroxybenzoate (1 mM) |
| 0.43 | 0.32 | 4.3 ± 0.0 | 0.49 | 0.50 |
Preferentially utilized substrates are highlighted in boldface. Applied substrate concentrations are indicated in parentheses. Values for maximal optical density (ODmax) and maximum specific growth rates (μmax) are based on three replicate cultures with standard deviations of below 5%. μmax was calculated from the slope of the active growth phase (m) according to μmax = m × 1/ΔOD. In the case of diauxic growth, phase 1 corresponds to the first active growth phase. In the case of monophasic growth, phase 1 corresponds to the only observed active growth phase. If present, phase 3 corresponds to a second active growth phase, with phase 2 representing the diauxic lag phase between phases 1 and 3 (Figure 1). For further details see Additional file 1: Figures S1–S3.
Anaerobic growth of sp. strain pMbN1 with a ternary mixture of 4-methylbenzoate, benzoate and succinate
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
| 4-Methylbenzoate (1 mM) |
| Succinate (5 mM) | 0.23 | 0.16 | 1.8 ± 0.1 | 0.62 | 0.31 |
For details see description to Table 1.
Figure 2Time-resolved profiles of selected transcripts and corresponding proteins (if identified by 2D DIGE) related to uptake and catabolism of benzoate (1ab), 4-methylbenzoate (2ab) and succinate (3abc). 4-Methylbenzoate-adapted cells of Magnetospirillum sp. strain pMbN1 were shifted to a ternary substrate mixture (see Figure 1d) of 4-methylbenzoate (adaptation substrate), benzoate (co-substrate) and succinate (co-substrate). Abbreviations for experiments with single substrates: M, 4-methylbenzoate; B, benzoate. The fold change in protein and ratio of transcript abundance were determined by comparison to succinate-adapted cells as reference. See legend to Figure 3 for name and predicted functions of selected transcripts/proteins. For detailed information see Additional file 1: Tables S1 and S2.
Figure 3Fold change in the abundance of proteins related to uptake and catabolism of benzoate (1ab), 4-methylbenzoate (2ab) and succinate (3abc) during anaerobic growth of sp. strain pMbN1 with substrate mixtures or single substrates (M, 4-methylbenzoate; B, benzoate; S, succinate; the adaptation substrate is listed first in each case). Sampling points for proteomic analyses are marked in green in the growth curves displayed on the left panel. Identified proteins are marked in blue. For further details (including abundance profiles of Had-1 and Had-2) see Additional file 1: Table S1. *, Transcript profiles of selected genes during growth with the ternary substrate mixture are shown in Figure 2. Protein names (in alphabetical order): (AcnB) aconitase 2, (BclA) benzoate-CoA ligase, (BcrCBAD) benzoyl-CoA reductase, (BenK) benzoate/H+ symporter, (Dch-1) cyclohex-1,5-diene-1-carbonyl-CoA hydratase, (Dch-2) 4-methylcyclohex-1,5-diene-1-carbonyl-CoA hydratase, (DctA) C4-dicarboxylate/Na+ symporter, (DctPQM) TRAP-type C4-dicarboxylate uptake transporter, (FumA) fumarate hydratase, (GltA) citrate synthase, (Had-1) 6-hydroxycyclohex-1-ene-1-carbonyl-CoA dehydrogenase, (Had-2) 6-hydroxy-4-methylcyclohex-1-ene-1-carbonyl-CoA dehydrogenase, (Icd) isocitrate dehydrogenase, (KorAB) 2-oxoglutarate:ferredoxin oxidoreductase, (MaeB) NADP+-dependent malic enzyme, (MbrCBAD) 4-methylbenzoyl-CoA reductase, (MclA) 4-methylbenzoate-CoA ligase, (Mdh) malate dehydrogenase, (Oah-1) 6-oxocyclohex-1-ene-1-carbonyl-CoA hydrolase, (Oah-2) 4-methyl-6-oxocyclohex-1-ene-1-carbonyl-CoA hydrolase, (Orf870–960) predicted ABC-type 4-methylbenzoate uptake transporter, (PdhABC, LpdA) pyruvate dehydrogenase complex, (SdhABCD) succinate dehydrogenase, (SucAB, Lpd) 2-oxoglutarate dehydrogenase complex, (SucDC) succinyl-CoA ligase. Compound names: 1, benzoate; 2, benzoyl-CoA; 3, cyclohex-1.5-diene-carbonyl-CoA; 4, 4-methylbenzoate; 5, 4-methylbenzoyl-CoA; 6, 4-methylcyclohex-1.5-diene-1-carbonyl-CoA; 7, succinate.